Improvements in depression and anxiety with brodalumab therapy in AMAGINE-1, a phase 3 study for moderate to severe plaque psoriasis

被引：0
|
作者：
Papp, Kim [1 ]
Reich, Kristian [2 ,3 ]
Paul, Carle [4 ]
Blauvelt, Andrew [5 ]
Toth, Darryl [6 ]
Langley, Richard G. [7 ]
Cather, Jennifer [8 ]
Gottlieb, Alice [9 ]
Li, Joanne [10 ]
Kricorian, Gregory [10 ]
机构：
[1] K Papp Med Res & Prob Med Res, Waterloo, ON, Canada
[2] Dermatologikum Hamburg, Hamburg, Germany
[3] SCIderm Res Inst, Hamburg, Germany
[4] Paul Sabatier Univ, Toulouse, France
[5] Oregon Med Res Ctr, Portland, OR USA
[6] XLR8 Med Res & Prob Med Res, Windsor, ON, Canada
[7] Dalhousie Univ, Halifax, NS, Canada
[8] Baylor Hlth Texas, Prob Med Res & Modern Dermatol, Modern Res Associates, Dallas, TX USA
[9] Tufts Med Ctr, Boston, MA USA
[10] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2016年 / 74卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
2863
引用
收藏
页码：AB254 / AB254
页数：1
相关论文
共 50 条
  • [1] Improvements in patient-reported outcomes (PROs) among moderate to severe plaque psoriasis patients treated with brodalumab: Results from AMAGINE-1
    Strober, Bruce
    Gordon, Kenneth
    Augustin, Matthias
    Viswanathan, Hema
    Klekotka, Paul
    Milmont, Cassandra
    Kricorian, Gregory
    Harrison, David
    Pinto, Lionel
    Nirula, Ajay
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB256 - AB256
  • [2] Relationship between PASI and DLQI scores and anxiety/depression in patients with moderate-to-severe psoriasis treated with brodalumab in the AMAGINE-1 trial
    Chiricozzi, A.
    Faurby, M.
    Hansen, J.
    Nielsen, V. Schultz
    Lacour, J. -P.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 51 - 51
  • [3] Efficacy and Safety of Brodalumab In Patients With Moderate To Severe Plaque Psoriasis: Results of AMAGINE-1, a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
    Papp, K.
    Reich, K.
    Blauvelt, A.
    Baran, W.
    Bolduc, C.
    Toth, D.
    Gottlieb, A. B.
    Thaci, D.
    Li, J.
    Nirula, A.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S8 - S8
  • [4] Efficacy and safety of brodalumab in patients with moderate to severe plaque psoriasis: Results of AMAGINE-1, a phase 3, randomized, double-Blind, placebo-controlled study
    Papp, Kim
    Reich, Kristian
    Leonardi, Craig
    Paul, Carle
    Blauvelt, Andrew
    Baran, Wojciech
    Bolduc, Chantal
    Toth, Darryl
    Langley, Richard G.
    Cather, Jennifer
    Gottlieb, Alice
    Thaci, Diamant
    Milmont, Cassandra E.
    Lim, Joanne
    Klekotka, Paul
    Kricorian, Greg
    Nirula, Ajay
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S8 - S8
  • [5] AMAGINE-3: A phase 3 study of efficacy and safety of brodalumab compared with placebo and ustekinumab in moderate to severe plaque psoriasis subjects
    Strober, Bruce
    Langley, Richard
    Blicharski, Tomasz
    Paul, Carle
    Lacour, Jean-Philippe
    Tyring, Stephen
    Kircik, Leon
    Chimenti, Sergio
    Duffin, Kristina Callis
    Bagel, Jerry
    Koo, John
    Aras, Gary
    Shi, Yifei
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB224 - AB224
  • [6] Efficacy and safety of brodalumab in patients with moderate to severe plaque psoriasis: Results of AMAGINE-1, a phase 3, randomized, double-blind, placebo-controlled study through week 12
    Papp, Kim
    Reich, Kristian
    Leonardi, Craig
    Paul, Carle
    Blauvelt, Andrew
    Baran, Wojciech
    Bolduc, Chantal
    Toth, Darryl
    Langley, Richard
    Cather, Jennifer
    Gottlieb, Alice
    Thaci, Diamant
    Milmont, Cassandra
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB233 - AB233
  • [7] AMAGINE-1: a phase 3, randomized, double-blind, placebo-controlled study of brodalumab in subjects with psoriasis
    Papp, K.
    Reich, K.
    Leonardi, C.
    Paul, C.
    Blauvelt, A.
    Baran, W.
    Bolduc, C.
    Toth, D.
    Langley, R. G.
    Cather, J.
    Gottlieb, A. B.
    Thaci, D.
    Milmont, C. E.
    Li, J.
    Klekotka, P.
    Kricorian, G.
    Nirula, A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (06) : E119 - E120
  • [8] Early Therapy Response to Brodalumab in Patients with moderate to severe Plaque Psoriasis
    Thio, H. B.
    Hansen, J. B.
    Ghislain, P-D
    Iversen, L.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 64 - 65
  • [9] Efficacy and Safety of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis and Skin of Color: Results from the Pooled AMAGINE-2/-3 Randomized Trials
    Amy McMichael
    Seemal R. Desai
    Aamir Qureshi
    Shipra Rastogi
    Andrew F. Alexis
    [J]. American Journal of Clinical Dermatology, 2019, 20 : 267 - 276
  • [10] Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3
    Papp, K. A.
    Gordon, K. B.
    Langley, R. G.
    Lebwohl, M. G.
    Gottlieb, A. B.
    Rastogi, S.
    Pillai, R.
    Israel, R. J.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (02) : 320 - 328
12345